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A B S T R A C T   
Classical swine fever (CSF) is among the most relevant viral epizootic diseases of swine. Due to its severe eco-
nomic impact, CSF is notifiable to the world organisation for animal health. Strict control policies, including 
systematic stamping out of infected herds with and without vaccination, have permitted regional virus eradi-
cation. Nevertheless, CSF virus (CSFV) persists in certain areas of the world and has re-emerged regularly. This 
review summarizes the basic established knowledge in the field and provides a comprehensive and updated 
overview of the recent advances in fundamental CSFV research, diagnostics and vaccine development. It covers 
the latest discoveries on the genetic diversity of pestiviruses, with implications for taxonomy, the progress in 
understanding disease pathogenesis, immunity against acute and persistent infections, and the recent findings in 
virus-host interactions and virulence determinants. We also review the progress and pitfalls in the improvement 
of diagnostic tools and the challenges in the development of modern and efficacious marker vaccines compatible 
with serological tests for disease surveillance. Finally, we highlight the gaps that require research efforts in the 
future.   
1. Introduction 
Classical swine fever (CSF) is considered one of the most relevant re- 
emergent viral diseases in swine (Postel et al., 2019; Xing et al., 2019). 
Considering its severe repercussions from an economic and sanitary 
standpoint, the disease is notifiable to the world organisation for animal 
health (OIE) (OIE, 2019a). The only natural reservoir of the aetiological 
agent, CSF virus (CSFV), are members of the Suidae family and the 
disease affects both domestic and wild pigs (Blacksell et al., 2006; 
Depner et al., 1995; Everett et al., 2011). CSFV (previously called Hog 
cholera virus) belongs to the Pestivirus genus within the Flaviviridae 
family, which also comprises the Flavivirus, Hepacivirus and Pegivirus 
genera (Simmonds et al., 2017, 2012). Other members of the Pestivirus 
genus, causing important diseases in animal health, include bovine viral 
diarrhoea virus-1 (BVDV-1), BVDV-2, and border disease virus (BDV). 
CSFV is an enveloped virus of icosahedral symmetry and viral 
particles measure between 40–60 nm in diameter. The viral genome is a 
single-stranded positive-sense RNA of approximately 12.3 kb in length 
with a single open reading frame (ORF) surrounded by two untranslated 
regions (UTRs), the uncapped 5′-UTR carrying an internal ribosome 
entry site (IRES), and the uridine-rich 3′-UTR. The ORF encodes a pol-
yprotein that is cleaved into four structural (capsid protein C, envelope 
glycoproteins Erns, E1 and E2) and eight nonstructural proteins (Npro, p7, 
NS2, NS3, NS4A, NS4B, NS5A and NS5B) (Lamp et al., 2011; Meyers 
et al., 1989; Moormann et al., 1990; Rijnbrand et al., 1997; Rümenapf 
et al., 1993, 1991). 
The first reports of CSF were from the Midwestern and Southern 
regions of the United States (US) and date back to 1810 in Tennessee. 
During the first half of the 19th century, outbreaks of CSF were reported 
in 10 different states in the US and, after 1860, the disease spread 
rapidly throughout the US territory, possibly related to the development 
of railways during the mid-century (Birch, 1922; Edwards et al., 2000). 
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The first reliable reports of CSF in Europe date back to 1862 in England. 
From there, the disease spread to Sweden, France and Denmark (Birch, 
1922), and from the 1960s on, it was present worldwide (Cole et al., 
1962). 
Recently, a reconstruction of the viral-host co-evolutionary history of 
the Pestivirus genus showed that, based on the time for the most recent 
common ancestor, CSFV emerged towards the end of the 18th century 
(Rios et al., 2017). It was hypothesized that this was likely due to a jump 
of Tunisian sheep virus (TSV) from the host Ovis aries to the new host, 
Sus scrofa. Coincidentally, the first import of Tunisian sheep to the US 
dates back to 1799 in Pennsylvania (Brier, 2013). The breed became 
very popular throughout the US, including some of the regions where 
CSF was reported for the first time (Carman et al., 1892; Peters, 1810). 
At that time, it was a common practice to keep animals of different 
species together in the same herds, favouring the hypothetical 
cross-species transmission of TSV to swine. The close genetic relation-
ship of CSFV with TSV and with other ovine pestiviruses described 
recently, supports that CSFV may have originated by a spillover of 
pestiviruses from sheep to pig (Postel et al., 2015; Rios et al., 2017; Sozzi 
et al., 2019; Wang et al., 2020). 
Since its emergence, CSF has always generated important economic 
losses in the swine industry. These are due to the high morbidity and 
mortality of the virus and to the severe restrictions imposed on pig and 
pork-derived products and trade (Meuwissen et al., 1999; Saatkamp 
et al., 2000). In addition, for an affected country or region, it is a com-
plex and costly process to recover a CSF-free status recognized by the 
OIE. A progressive eradication programme has been implemented in 
Europe since the 1990s (Paton and Greiser-Wilke, 2003), which 
included strict serological surveillance accompanied by stamping out of 
infected and contact animals under a non-vaccination policy for do-
mestic pigs (Anonymous, 2001). The costs resulting from the last two 
CSF outbreaks in Spain (1997 and 2001) were around 108 million Euros 
combined (Fernández-Carrión et al., 2015). The outbreak in 1997/98 in 
the Netherlands had a total estimated cost of over 2 billion US$. The 
majority of these costs were related to “welfare sacrifice”, in which 
healthy animals outside of the control zones had to be euthanized due to 
the movement restrictions (Elbers, 2002; Meuwissen et al., 1999). 
Notably, the ethical and animal welfare implications of such practices 
were controversial. 
Currently, the OIE list of CSF-free territories consists of 38 countries, 
including all of North America, Oceania, as well as a large part of the 
European Union (EU) (OIE, 2019b). CSF remains endemic in Asia, South 
and Central America and the Caribbean, while the OIE has declared 
specific regions of Brazil, Colombia and Ecuador free of the disease, even 
if the countries remain endemic (OIE, 2019b). The CSF situation in Af-
rica is largely unknown, even though outbreaks have been reported in 
Madagascar and South Africa (Ji et al., 2015; Sandvik et al., 2005). 
According to the world animal health information system (WAHIS), the 
most recent CSF outbreaks have been reported in Korea, Colombia, 
Russia, Brazil and Japan (OIE, 2019c). In the case of Japan, after 26 
years of CSF-free status, the disease has re-emerged in both domestic 
pigs and wild boar (OIE, 2019c; Postel et al., 2019). In contrast to the 
policy adopted by the majority of EU countries for the eradication of CSF 
in the past, the Japanese government has implemented preventive 
vaccination in domestic pigs for the control of the recent CSFV outbreak 
(Isoda et al., 2020). However, similarly to Europe, in Japan, the infected 
wild boar populations represent a risk for domestic pigs (Fritzemeier 
et al., 2000; Ito et al., 2019). Additionally, the endemic countries pose a 
constant challenge for surveillance programs in CSF-free territories. 
Thus, CSFV remains an endemic and re-emerging virus in pigs and 
continues to threaten pork production worldwide and the food security 
of populations in developing countries. Considering the ongoing 
importance of CSF to the global pig industry, the present review aims to 
provide a comprehensive and updated overview of; CSFV taxonomy and 
evolution, CSF pathogenesis and host immunity, virus-host interactions 
and viral virulence, the state-of-the-art in CSFV diagnostics and, finally, 
progress and perspectives in vaccine development. 
2. Taxonomy of CSFV and related pestiviruses 
In contrast to BVDV-1, BVDV-2 and BDV, which infect a wide range 
of ruminant species and pigs, CSFV has a narrow host range restricted to 
domestic pigs, wild boar as well as other members of the family Suidae 
(Everett et al., 2011; Postel et al., 2018). Due to a growing number of 
novel pestiviruses detected in pigs, in domestic and wild ruminants, and 
in other mammalian host species not belonging to the order Artiodactyla, 
the taxonomy of the genus Pestivirus, including the nomenclature of the 
different Pestivirus species, has been revised recently by the Flaviviridae 
Study Group of the International Committee on Taxonomy of Viruses 
(Simmonds et al., 2017; Smith et al., 2017). Seven novel species were 
added to the four approved members (BVDV-1, BVDV-2, CSFV, and 
BDV) of the genus, and today Pestivirus species are named in a 
host-independent manner using the format Pestivirus X, which results in 
the eleven recognized species Pestivirus A to K (Smith et al., 2017). These 
changes refer to the nomenclature of virus species names, while the 
original virus names for the established pestiviruses and virus isolates 
are maintained. In addition to these eleven species, several novel 
tentative Pestivirus species were found recently in pigs, ruminants, ro-
dents, bats, whales, and pangolins (Becher et al., 2020; Firth et al., 2014; 
Gao et al., 2020; Jo et al., 2019; Lamp et al., 2017; Sozzi et al., 2019; Wu 
et al., 2018, 2012). Under natural conditions, pigs can be infected with 
CSFV (Pestivirus C), BVDV-1 and -2 (Pestivirus A and B), BDV (Pestivirus 
D), and atypical porcine pestivirus (APPV, Pestivirus K). Moreover, 
genetically distinct pestiviruses like Bungowannah virus (Pestivirus F) 
and Linda virus can infect pigs and have caused unique disease episodes 
in single farms characterized by myocarditis and congenital tremor, 
respectively (Kirkland et al., 2007; Lamp et al., 2017). So far, attempts to 
confirm the presence of similar viruses in domestic pig and wild boar 
failed, and the natural hosts of Bungowannah virus and Linda virus 
remain unknown (Cagatay et al., 2018). The most widely distributed 
Pestivirus in domestic pigs and wild boar is APPV followed by CSFV, 
while infections of pigs and wild boar with ruminant pestiviruses are 
rare events (Becher et al., 2020; Postel et al., 2018, 2017b). 
3. Genetic variability of CSFV 
Replication of viral RNA genomes by CSFV and other pestiviruses is 
mediated by viral RNA-dependent RNA polymerases (RdRP) lacking 
proofreading activity (Becher and Tautz, 2011). The accumulation of 
point mutations under selective pressure represents the major driving 
force for CSFV evolution resulting in the emergence of genetically highly 
variable CSF viruses. Three major CSFV genotypes (1, 2, and 3) have 
been described. Genotype 1 can be further divided into seven sub-
genotypes (1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7), while three subgenotypes 
(2.1, 2.2, 2.3) have been reported for genotype 2 (Garrido Haro et al., 
2018; Postel et al., 2013b, 2012; Silva et al., 2017). More recently, it has 
been proposed to rename previously identified subgroups within sub-
genotypes 2.1 and 2.2, resulting in the segregation of genotype 2 CSFV 
strains into seven subgenotypes (2.1–2.7) and the establishment of two 
additional genotypes (4 and 5) (Rios et al., 2018). These latter two ge-
notypes comprise the distantly related CSFV strain “congenital tremor” 
(Great Britain/1964) and two strains from Korea (KR/1998, KR/1999) 
(Fig. 1). 
Molecular typing of CSFV isolates allows discrimination of virus 
isolates and can help trace the source of an outbreak. Historically, ge-
netic typing of CSFV isolates was based on phylogenetic comparison of 
rather small viral genomic regions including a 150 nucleotide (nt) 
sequence of the 5′-UTR, a partial E2 encoding sequence of 190 nt, or a 
409 nt fragment from the polymerase gene (Lowings et al., 1996; Paton 
et al., 2000; Vilček et al., 1996). Comparison of such short sequences 
provided usually the allocation of virus isolates to one of the three major 
genotypes and in many cases to a defined subgenotype. Determination of 
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longer sequences has become more feasible, and the use of complete E2 
encoding sequences was recommended for more detailed and statisti-
cally sound phylogenetic analyses, resulting in more reliable discrimi-
nation of closely related CSFV isolates obtained during 
epidemiologically linked outbreaks (Postel et al., 2012). Today, phylo-
genetic analysis of this genomic region represents the commonly 
accepted standard for genetic typing of CSFV isolates (Garrido Haro 
et al., 2018; Jiang et al., 2013; Postel et al., 2019, 2013a, 2013b, 2012, 
Rios et al., 2018, 2017; Silva et al., 2017; H. Zhang et al., 2015a, 2015b). 
A large number of CSFV sequences, including more than 400 complete 
E2 encoding sequences, is deposited in the CSF database at the EU & OIE 
Reference Laboratory for CSF at the University of Veterinary Medicine in 
Hannover, Germany and can be accessed upon request (Postel et al., 
2016). Moreover, high-throughput sequencing has facilitated the 
establishment of complete viral genomic sequences, and subsequent 
analyses can even provide insights into the role of viral quasispecies 
(Fahnøe et al., 2014; Töpfer et al., 2013). 
4. Pathogenesis and immunity 
4.1. CSF pathogenesis 
CSFV is transmitted through the oronasal route, by direct or indirect 
contact with infected pigs, as well as through consumption of contam-
inated feed. Vertical transmission from infected sows to their offspring 
can also occur (Moennig et al., 2003). Considering that CSFV is shed 
from all mucosal surfaces and has also been found in semen, the virus 
may also be transmitted through insemination (Floegel et al., 2000). 
CSFV has also been reported to survive over long periods in cooled and 
frozen meat and pork derivate products, which can be reservoirs for the 
virus (Edwards, 2000). 
The virus infects primarily the epithelial cells of tonsillar crypts, 
regardless of the entry route and afterwards, it invades the lymphoid 
tissues (Ressang, 1973; Trautwein, 1988). After entering the lymphatic 
capillaries, the virus is carried to the regional lymph nodes and enters 
the efferent blood capillaries giving rise to viremia. Thereafter, the virus 
reaches the bone marrow and secondary lymphoid organs, such as the 
spleen, lymph nodes and lymphoid structures associated with the small 
intestine, wherein it replicates. Late in the viremic phase, the paren-
chymatous organs are invaded (Belák et al., 2008; Liu et al., 2011; 
Ressang, 1973). 
CSFV has a particular affinity for endothelial cells and the mono-
nuclear phagocyte system, i.e. macrophages and dendritic cells (DCs) 
(Knoetig et al., 1999; Ressang, 1973; Summerfield and Ruggli, 2015; 
Trautwein, 1988), which are central in orchestrating innate and adap-
tive immune responses (McCullough et al., 2009; Pulendran et al., 
2001). DCs are primarily responsible for the initial recognition of 
pathogens and regulation of the early phases of the induced immune 
response, as well as the presentation of antigen associated with SLA class 
I and class II. After infection, CSFV induces proliferation of DCs without 
interfering with their maturation and antigen presentation capacity, 
thus, serving as a vehicle for virus spread in the organism (Jamin et al., 
Fig. 1. Genetic variability of CSFV. For 
phylogenetic analysis, 53 complete E2 encoding 
sequences (1119 nt) were aligned by Clustal W 
and genetic distances were calculated with the 
Kimura 2-parameter substitution model using 
the Mega X software. Maximum likelihood 
construction of the tree included 100 repeti-
tions for bootstrap analysis (values of 70 or 
higher are indicated). For each sequence, 
country of origin, year of isolation and GenBank 
number are given. Indicated are genotypes (gt.) 
1-5 and corresponding subgenotypes (1.1-1.7, 
2.1-2.7); gt.4, gt.5 as well as subgenotypes 1.5- 
1.7 and 2.4-2.7 recently proposed by Rios et al. 
(2018) are shown in grey.   
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2008). Likewise, the virus exploits the migratory ability of granulocytes 
and macrophages, using these cells as a “Trojan horse” for its dissemi-
nation to other organs in the body (Carrasco et al., 2004; 
Muñoz-González et al., 2015b). 
CSFV infection leads to a breakdown of the immune system which, 
accompanied by an aberrant pro-inflammatory response (referred to as a 
“cytokine storm”), is unable to control disease progression (Knoetig 
et al., 1999; Sánchez-Cordón et al., 2005b, 2002; Summerfield et al., 
2006; Tarradas et al., 2010). The disease is associated with severe 
lymphopenia and lymphocyte apoptosis (Summerfield et al., 1998b; 
Susa et al., 1992), thrombocytopenia, platelet aggregation (Bautista 
et al., 2002), bone marrow depletion affecting myelopoiesis and mega-
karyocytopoiesis (Gómez-Villamandos et al., 2003; Summerfield et al., 
2000), and thymus atrophy as well as thymocyte apoptosis (Pauly et al., 
1998; Sánchez-Cordón et al., 2002). Lymphoid depletion is generalized, 
not only affecting peripheral blood and lymph nodes but also the 
mucosal tissue (Gómez-Villamandos et al., 2003), with an altered pop-
ulation of T cells and depletion of lymphocytes (Pauly et al., 1998; Van 
Oirschot et al., 1983), mainly CD4+ and CD8+ T cells (Summerfield 
et al., 2001). In this regard, CSFV infection promotes marked bystander 
apoptosis of the surrounding uninfected B and T cells, by mechanisms 
that are still not completely understood, contributing to the strong 
immunosuppression and high mortality rates (Carrasco et al., 2004; 
Ganges et al., 2008; Summerfield et al., 2001, 1998b; Susa et al., 1992). 
Depending on the virulence of the CSFV strain, pigs can have up to 90 % 
of their total T cells depleted in the final stages of the disease (Pauly 
et al., 1998). This effect can be observed as early as one day after 
infection, even before viremia has been established (Summerfield et al., 
1998b), much earlier than seroconversion and clinical signs of disease, 
which is relevant both, for early diagnosis and for the study of viral 
pathogenesis (Ganges et al., 2008; Pauly et al., 1998; Summerfield et al., 
2000, 1998b). CSFV infection has been related with interleukin (IL)-10 
production by CD4-/CD8+ T cells, which might be implicated too in the 
immunosuppression observed after infection (Muñoz-González et al., 
2015b; Suradhat et al., 2005). 
In advanced phases of the disease granulocytopenia is observed, 
which is followed by the circulation of immature precursors in periph-
eral blood (Bohórquez et al., 2019a; Ganges et al., 2005; 
Muñoz-González et al., 2015b; Nielsen et al., 2010; Summerfield et al., 
1998a). In the bone marrow, the main targets of infection are immature 
myeloid cells SWC3+/SWC8-, as well as the less-differentiated 
SWC3low/SWC8- myeloid precursor cells, which differentiate towards 
SWC8+ granulocytic and 6D10+ cells (Muñoz-González et al., 2015b; 
Summerfield et al., 2001, 2000). This finding explains the occurrence of 
infected peripheral blood granulocytes during CSF (Bohórquez et al., 
2019a; Summerfield et al., 2001, 1998a). 
4.2. Humoral and cellular immunity against CSFV 
After infection, the increase of interferon (IFN)-γ-secreting T lym-
phocytes, consisting mainly of CD4-/CD8+ effector cytotoxic T lym-
phocytes (CTLs), contributes to the early control of viral replication and 
protects against leukopenia before the onset of neutralizing antibodies 
(Franzoni et al., 2013; Graham et al., 2012a; Piriou et al., 2003; Tarradas 
et al., 2010). In addition, activated CD4+/CD8+/CD25+ memory T 
cells contribute to the early control of viral replication. The CD4+ T cells 
and the CTLs are induced from one to three weeks after CSFV infection 
(Ganges et al., 2008; Piriou et al., 2003). The E2 and NS3 viral proteins 
are the main inducers of the specific CTL response (Ceppi et al., 2005; 
Ganges et al., 2008; Graham et al., 2012b). 
The initial Th1 cytokine expression (IL-2 and IFN-γ) switches later on 
to a Th2 response (IL-4, IL-10), helping the differentiation of B cells to 
immunoglobulin-producing plasma cells (Sánchez-Cordón et al., 
2005a). Despite the strong activation of T cell immunity, this response 
has only been related to partial protection against CSFV infection 
(Franzoni et al., 2013; Graham et al., 2012b; Summerfield and Ruggli, 
2015; Tarradas et al., 2014, 2011). 
It is worth noting that the neutralizing antibody (Ab) response ach-
ieves sterilizing protection against CSFV (Blome et al., 2017a; Ganges 
et al., 2008, 2005; van Oirschot, 2003v). CSFV neutralizing Ab titres 
higher than 1/32 can be protective, preventing viral excretion and 
transmission (Terpstra and Wensvoort, 1988). The antibodies induced in 
infected pigs recognize Erns, E2 and NS3 proteins (Graham et al., 2012b; 
Greiser-Wilke et al., 1992; König et al., 1995; Weiland et al., 1992). 
Anti-NS3 antibodies cross-react with NS3 of different pestiviruses and 
are not neutralizing (Weiland et al., 1992). Neutralizing antibodies 
against E2, the most immunogenic CSFV protein, are produced between 
10 and 20 days after natural infection (König et al., 1995; Terpstra and 
Wensvoort, 1988; Van Rijn et al., 1996) and are the only antibodies able 
to confer clinical protection against CSFV challenge (Rümenapf et al., 
1991). Therefore, this protein is the main target for the development of 
recombinant vaccines against CSFV and other pestiviruses. 
Maternal-derived antibodies (MDA) can be transmitted by sows to 
their offspring via colostrum, which can protect piglets against disease 
during the first weeks of life, although MDA do not prevent CSFV 
replication and excretion completely (van Oirschot, 2003v). As piglets 
grow older, the protection by MDA decreases (van Oirschot, 2003v; 
Vandeputte et al., 2001). However, MDA can interfere with the devel-
opment of vaccine-induced immunity, an aspect to keep in mind for 
immunisation schedules (Blome et al., 2017a). 
5. The clinical forms of CSF 
The clinical signs of CSF are highly variable and determined by the 
virulence of the viral strain, the host’s immune responses, the age, 
breed, genetic background, the general health condition of the pigs, as 
well as by concomitant infections (Belák et al., 2008; Borca et al., 2019; 
Cao et al., 2018; Ganges et al., 2008; Tarradas et al., 2014; Trautwein, 
1988; von Rosen et al., 2013v). The clinical forms of CSF can follow 
peracute, acute, subacute, chronic or unapparent subclinical courses 
(Ganges et al., 2008; van Oirschot and Terpstra, 1989v). The majority of 
experimental studies focus on the characterization of acute disease after 
inoculation with virulent strains, characterized by a short incubation 
period, accompanied by scarce signs, and rapid mortality within a few 
days after exposure (Belák et al., 2008; Dune, 1973; Hüsser et al., 2012; 
Knoetig et al., 1999; Tarradas et al., 2014). The chronic and unapparent 
forms of disease are observed mostly in endemic areas, where they may 
be misdiagnosed and become a source of new CSF outbreaks (Coronado 
et al., 2019a; Floegel-Niesmann et al., 2003; Ji et al., 2014; Pérez et al., 
2012; Shen et al., 2011; Wensvoort and Terpstra, 1985). 
5.1. The acute form of CSF 
Acute CSF is caused typically by highly virulent strains, although 
strains of moderate virulence can also trigger this form of infection. It is 
more frequent in piglets up to 12 weeks of age, while milder forms are 
usually observed in older pigs (Moennig et al., 2003; Muñoz-González 
et al., 2017). After a short incubation period (two to six days after 
exposure), pigs develop a sustained pyrexia (>40 ◦C) (Belák et al., 2008; 
Mittelholzer et al., 2000; Moennig et al., 2003; Tarradas et al., 2014). In 
peracute cases, no gross changes are found at necropsy. Highly virulent 
CSFV strains cause marked immunosuppression and high mortality 
(Gómez-Villamandos et al., 2003; Lee et al., 1999; Susa et al., 1992). 
Leukopenia (less than 8000 cells/μl in blood) appears rapidly, even 
before the animals show fever or viremia (Stegeman et al., 2000). In 
addition, thymus atrophy has also been described in acute forms of CSF, 
wherein massive lymphoid depletion was also found due to lymphocyte 
apoptosis (Sánchez-Cordón et al., 2002). 
As a result of central nervous system infection, pigs show progressive 
depression and uncoordinated movements (Ganges et al., 2005; Moen-
nig, 2000). The most characteristic feature is the haemorrhagic syn-
drome, including petechiae of the skin, mucosae, and cyanosis of the 
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abdomen, ears, snout and medial side of the extremities. Clinical find-
ings include conjunctivitis, constipation followed by severe diarrhoea 
(“cholera”), tremor, locomotive disturbance, reluctant walking, swaying 
movement of the hindquarter, posterior paresis, mild to severe convul-
sions and prostration in the terminal phase (Mittelholzer et al., 2000; 
Tarradas et al., 2014; van Oirschot, 2004v). The lethality is close to 100 
%, with death occurring between 10–20 days post-infection (Dune, 
1975; Moennig et al., 2003). In general, the typical pathologic lesions 
consist of swollen or haemorrhagic lymph nodes and petechial bleedings 
of the tonsils and the inner organs and serosa, especially the 
gastro-intestinal tract, kidneys, spleen and lymph nodes (Belák et al., 
2008; Gómez-Villamandos et al., 2003, 2000). In peracute/acute cases 
however, these pathologic lesions can often be inconspicuous or inex-
istent. The subacute form manifests also with pyrexia, diarrhoea, central 
nervous disorders, but the symptoms are less severe and lethality is 
lower (Floegel-Niesmann et al., 2009a, 2003). The surviving animals 
generate long-lasting and robust humoral immunity, characterized by 
the presence of neutralizing antibodies appearing after two weeks 
post-infection (Chander et al., 2014; Moennig et al., 2003). 
5.2. The chronic form of CSF 
In general terms, an infection is considered as chronic when the 
survival of infected animals exceeds 30 days (Dune, 1975; Liess, 1984; 
Muñoz-González et al., 2015b). The chronic form of CSF occurs usually 
when the pigs are not able to develop an effective immune response 
against the infection (Petrov et al., 2014a; Tarradas et al., 2014). 
Considering that, chronic infections can be established in the presence of 
neutralizing antibodies (Mengeling and Packer, 1969). The chronic form 
of the disease manifests with stunting, anorexia, and intermittent py-
rexia and diarrhoea. In a first phase, the clinical picture can be similar to 
the acute form of CSF. After overcoming the initial phase, clinical signs 
can disappear and animals can appear apparently healthy (Mengeling 
and Cheville, 1968). Over time, however, the disease progresses with 
nonspecific signs, with the re-occurrence of intermittent fever, diarrhoea 
and wasting, which are not always easy to identify in the farm (Moennig 
et al., 2003). CSFV is shed from the onset of clinical signs until death. 
The affected animals can survive up to 2–3 months after exposure 
(Weesendorp et al., 2011). 
In the chronic form, the Ab response is insufficient to eliminate the 
virus. The antibodies are not always detectable because they are bound 
by the virions. These immune complexes can deposit in the kidney and 
cause a characteristic glomerulonephritis (Choi and Chae, 2003a, 
2003b; Gómez-Villamandos et al., 2000). The post-mortem changes are 
not very characteristic of the disease and haemorrhagic lesions may not 
always be present. However, it is quite common to find thymus atrophy 
(Cheville and Mengeling, 1969), ulcerative and necrotic lesions ("button 
ulcers") in the ileocecal valve in animals with chronic diarrhoea, as well 
as along the ileum and colon (Blome et al., 2017b). Necrotic ulcers are 
also common in epiglottis and larynx. Secondary bacterial infections are 
frequent (Cheville and Mengeling, 1969; Choi and Chae, 2003a, 2003b; 
Coronado et al., 2019a). Overall, the rather unspecific clinical signs and 
pathologic findings in this form may be confused with other diseases, 
that should be included in the differential diagnosis (Elbers et al., 2003; 
Moennig et al., 2003; Rout and Saikumar, 2012). 
5.3. Congenital persistent CSFV infection 
It is well established that transplacental transmission of CSFV can 
lead to the generation of persistently infected offspring, especially if the 
infection takes place during mid-gestation, a phenomenon known as 
“carrier sow syndrome” (Aynaud et al., 1977; Carbrey et al., 1977; Liess, 
1984; Van Oirschot, 1979a, 1979b; Van Oirschot and Terpstra, 1977). 
Moreover, depending on viral virulence and on the time of infection 
during gestation, transplacental infection may result in abortion, still-
birth, mummification, malformations, or in the birth of weak, or 
apparently healthy, piglets persistently infected with CSFV (Bohórquez 
et al., 2020; Trautwein, 1988). 
Persistently infected piglets are not able to induce Ab responses 
against CSFV and they have lifelong viremia (Bohórquez et al., 2020; 
Coronado et al., 2019a; de Smit et al., 2000d; Van Oirschot, 1979b). 
Even though they may appear clinically healthy at birth, or may show 
unspecific clinical signs, such as poor growth, wasting or occasionally 
congenital tremor, they invariably die from CSF. The development of 
mild anorexia, depression, conjunctivitis, dermatitis, diarrhoea, runting, 
and locomotive disturbance leading to paresis and eventually death, 
may take several months (Trautwein, 1988). Survival for up to 11 
months after birth has been reported (Coronado et al., 2019a; Van 
Oirschot and Terpstra, 1977). This course of infection is referred to as 
“late-onset CSF” (van Oirschot and Terpstra, 1989). Persistently infected 
piglets act as a viral reservoir and spread the virus while remaining 
undetected in serological tests (Coronado et al., 2019a; van Oirschot, 
2004v; Van Oirschot and Terpstra, 1977). These animals are refractory 
to vaccination and contribute to virus circulation in regions where the 
disease is endemic (Coronado et al., 2019a). The occurrence of persis-
tently infected animals is favoured by the prevalence of lower virulence 
strains in these regions as a result of a positive selection pressure exerted 
by inefficient vaccination (Coronado et al., 2019b; Ji et al., 2014; Rios 
et al., 2017). 
The mechanisms underlying the establishment of congenital CSFV 
persistent infection have been related to a specific immunotolerance to 
the virus (Carbrey et al., 1977; Trautwein, 1988; Van Oirschot and 
Terpstra, 1977; Vannier et al., 1981). This immunotolerance was 
attributed to a lack of pathogen recognition due to the immature state of 
the fetal immune system. However, it was demonstrated recently that 
fetuses are able to generate an innate immune response against CSFV 
after transplacental transmission, in terms of IFN-α induction, indicating 
that the virus can be recognized as a pathogen by the fetal innate im-
mune system (Bohórquez et al., 2020). This suggests that the immuno-
logical phenomena involved in the establishment of congenital 
persistent CSFV infection is more complex than previously thought and 
warrants further study (Van Oirschot, 1979b; Van Oirschot and Terpstra, 
1977). 
Notably, immunosuppressive cell populations, known as myeloid- 
derived suppressor cells (MDSC), were found to be increased in cord 
blood and neonatal peripheral blood, playing a homeostatic role in 
maternal-fetal tolerance (Rieber et al., 2013). These cell populations 
may favour the establishment of CSFV persistent infection in fetuses 
(Bohórquez et al., 2019a). 
5.4. Postnatal persistent CSFV infection 
The capacity of CSFV to induce viral persistence following postnatal 
infection has also been demonstrated in both domestic pigs and wild 
boars (Cabezón et al., 2015; Muñoz-González et al., 2015b). This form of 
disease has been described after infection of newborn piglets, and ani-
mals up to three weeks of age, with a moderately virulent CSFV strain 
(Bohórquez et al., 2019b; Muñoz-González et al., 2015b). Piglets that 
develop persistent CSF after postnatal infection will appear clinically 
healthy or have unspecific clinical signs while showing high viral 
replication and shedding in the absence of adaptive immune response 
against the virus. By contrast, the innate immune response to the virus, 
in terms of IFN-α in serum, is not affected in these persistently infected 
piglets at seven days post-infection. However, the IFN-α pathway is 
subsequently impaired in these animals as they fail to mount an IFN-α 
response six weeks after infection, even against pathogens such as Af-
rican swine fever virus that induce exacerbated IFN-α responses 
(Cabezón et al., 2017). The lack of immune responses in persistently 
infected pigs has been related to immunosuppression, since these ani-
mals were not able to elicit any immune response, neither against CSFV 
nor other antigens (Muñoz-González et al., 2015b). 
Age plays an important role for the pathogenesis of postnatal 
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persistent CSFV infection: a lower proportion of offspring were persis-
tently infected when the infection was carried out at three weeks of age, 
compared with infection a few hours after birth (Bohórquez et al., 
2019b; Muñoz-González et al., 2015b). In CSFV postnatal persistently 
infected piglets a low CD4/CD8 ratio was detected (Bohórquez et al., 
2019b). This suggests that these animals may be in a state of immune 
exhaustion, a phenomenon in which chronic stimulation of the immune 
system by a pathogen leads to its premature aging and to differentiation 
of cells to terminal states (Yao and Moorman, 2013). In addition, it has 
been reported that precursor myeloid cell populations were increased in 
the bone marrow and peripheral blood of piglets with postnatal persis-
tent CSFV infection (Bohórquez et al., 2019a; Muñoz-González et al., 
2015b). These cells were found to be phenotypically and functionally 
similar to immunosuppressive MDSC populations found in humans 
(Bohórquez et al., 2019a). In particular, the phenotype of the 
6D10+/CD11b+/CD33+ MDSC found in persistently infected piglets 
indicated that these cells belong to the polymorphonuclear-MDSC 
(PMN-MDSC) subset and not the monocytic-MDSC (M-MDSC) (Fig. 2). 
MDSC subsets have been found to play a role during persistent infection 
in humans and recently have been implicated in impairing immune 
checkpoint therapy in cancer (Serrano-Villar et al., 2014; Tacke et al., 
2012; Weber et al., 2018). As previously mentioned, MDSC are increased 
in cord blood and during neonatal stages, which may explain the higher 
proportion of persistently infected piglets when the animals are infected 
with CSFV a few hours after birth compared to infection of 3 week-old 
animals. Moreover, the immunomodulatory capabilities of MDSC may 
block the onset of exacerbated immune responses, despite the high viral 
replication in persistently infected animals, favouring the survival of 
these animals for long periods without any clinical signs associated with 
CSF. Nevertheless, further studies are needed to gain an in-depth 
Fig. 2. Schematic representation of the generation and mechanisms of immune suppression of MDSC populations. Haematopoietic stem cells can be 
differentiated into cell populations promoting a pro-inflammatory status in the animal following stimulation by an antigen (left side, purple cells and cytokines). 
When the immune response does not lead to the elimination of the pathogen, the chronic antigenic stimulation may lead to abnormal myelopoiesis, resulting in the 
generation of MDSC populations with immunomodulatory properties (right side, red cells and cytokines). The phenotype indicated in the graphic corresponds to the 
cellular markers attributed to MDSC populations in humans. The specific mechanisms of pro-inflammatory and immunomodulatory cell populations are detailed in 
the lower part of the graphic. The asterisk indicates cells that have been characterized in swine during postnatal persistent CSFV infection (phenotype 6D10+ CD33+
CD11b+) according to (Bohórquez et al., 2019a). Image created with Biorender.com. 
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understanding of the role of immune exhaustion and MDSC in the 
pathogenesis of postnatal persistent CSFV infection, as well as their 
possible therapeutic roles against viral infections in animals and 
humans. 
5.5. CSFV and the superinfection exclusion (SIE) phenomenon 
The SIE phenomenon, or homologous interference, is defined as the 
capacity of a primary viral infection to interfere with a secondary 
infection by the same or a closely related virus (Folimonova, 2012; Karpf 
et al., 1997; Y.-M. Lee et al., 2005a, 2005b; Ramírez et al., 2010). This 
phenomenon fulfils a conservative strategy, from an evolutionary point 
of view, reducing the likelihood of recombination events between 
related strains, favouring the stability of viral sequences within the same 
cell (Formella et al., 2000; Huang et al., 2008; Lee et al., 2005a, 2005b). 
SIE has been applied in the treatment and prevention of viral infections. 
A widely accepted practice is the cross-protection of crops by purposeful 
infection with milder virus isolates, which is an effective and economical 
antiviral management strategy (Gal-On and Shiboleth, 2006). It has also 
been proposed that transplantation of hepatitis C virus (HCV)-infected 
liver grafts may be useful for the treatment of HCV-infected patients, 
considering that SIE would prevent re-infection of the transplanted or-
gans, whereas healthy organ transplants would be damaged rapidly 
(Y.-M. Lee et al., 2005a, 2005b; Webster et al., 2013). With pestiviruses, 
acute infection of cells with BVDV protected them from a second 
infection by a homologous BVDV strain (Y.-M. Lee et al., 2005a, 2005b). 
Also, cells persistently infected with CSFV were resistant to superinfec-
tion and protected from infection by a cytopathic strain (Mittelholzer 
et al., 1998). 
Even though multiple studies have demonstrated the SIE phenome-
non in vitro, very few reports have proven the occurrence of SIE at the 
organism level (Bergua et al., 2014; Campbell et al., 2014; Walters et al., 
2004). An interesting finding was that piglets persistently infected with 
CSFV after postnatal infection were refractory to vaccination with a 
lapinised CSFV C-strain vaccine (Muñoz-González et al., 2015a). The 
fact that vaccine RNA could not be detected by vaccine-specific RT-qPCR 
in these animals suggested a phenomenon of SIE, in which the high viral 
load of the primary persistent infection was able to block a secondary 
infection by the CSFV vaccine strain. A separate study found that such 
persistently infected piglets were protected from acute disease after 
inoculation with the highly virulent CSFV Margarita strain, indicating 
an efficient suppression of the secondary infection in the persistently 
infected animals (Muñoz-González et al., 2016). The absence of IFN-α 
and the lack of IFN-γ producing cells in the persistently infected animals 
after the secondary infection with the Margarita strain indicated a state 
of immunosuppression, which suggests SIE in these animals (Cabezón 
et al., 2017, 2015, Muñoz-González et al., 2015a, 2015b). This reduction 
of type I and II IFN responses may promote the maintenance of a high 
and constant CSFV load, preventing the secondary viral entry. 
Even though the SIE mechanism needs to be studied in greater depth, 
it cannot be ruled out that it is playing a role in CSFV evolution, likely 
favouring the prevalence of strains with high replication capacity 
(Huang et al., 2020; Mittelholzer et al., 1998; Muñoz-González et al., 
2016). Likewise, it may also have an impact on disease control, partic-
ularly by affecting the efficacy of vaccination with live attenuated vac-
cines. The model of persistent CSF after early postnatal infection 
constitutes the first demonstration of the SIE mechanism at a systemic 
level in a mammalian host. A better understanding of the mechanisms 
behind this phenomenon and its potential future applications require 
further studies. 
6. Virus-host interaction 
6.1. The virus life cycle 
Among the three Pestivirus surface glycoproteins, E2 and Erns mediate 
attachment and interaction with the cellular receptors, while E1 is 
involved in fusion and entry (S. Li et al., 2017a, 2017b; Tautz et al., 
2015; F.-I. Wang et al., 2015a, 2015b). As for many viruses, initial 
attachment of pestiviruses with the host cell occurs via heparan sulphate 
(HS)-containing glycosaminoglycans, which is a rather unspecific 
mechanism mediated essentially by Erns (Cheng et al., 2019; 
Eymann-Häni et al., 2011; Hulst et al., 2000; Iqbal and McCauley, 2002; 
van Gennip et al., 2004v). In addition to HS binding, Erns attaches also to 
the laminin receptor (Chen et al., 2015). CD46 plays also a role in CSFV 
entry but its receptor function through interaction with E2 is not as clear 
as for BVDV (Dräger et al., 2015; Maurer et al., 2004). While antibodies 
against CSFV E2 can prevent cell entry completely, antibodies against 
porcine CD46 can only partially inhibit infection, even when combined 
with HS blockers, suggesting a contribution of additional co-receptors 
(Dräger et al., 2015). Integrin β3 is also required for efficient infection 
and replication, and CSFV induces its upregulation in vascular endo-
thelial cells (W. Li et al., 2014a, 2014b; Tang et al., 2010). 
After binding to the cell surface receptors, CSFV enters via caveolin-1 
and clathrin-mediated endocytosis, a pH-dependent process that in-
volves dynamin and cholesterol and depends on the small GTPases 
Rab5, 7 and 11 (Ning et al., 2016; Shi et al., 2016; Y.-N. Zhang et al., 
2018a, 2018b, 2018c). E2 plays a central role in CSFV entry and 
membrane fusion since two fusion peptides were identified on E2 
(Fernández-Sainz et al., 2014; Holinka et al., 2016). It acts probably as a 
heterodimer with E1, as suggested by a study with BVDV (Ronecker 
et al., 2008) and reviewed elsewhere (F.-I. Wang et al., 2015a, 2015b). 
Recently, the membrane protein MERTK, a member of the TAM (Tyro3, 
Axl and MerTK) receptor tyrosine-protein kinases, was found to promote 
virus entry through interaction with E2 (Zheng et al., 2020). E2 interacts 
also with β-actin, which may further assist virus entry and early repli-
cation (F. He et al., 2014a, 2014b). There is also increasing evidence for 
the importance of cellular cholesterol in CSFV entry. Disruption of 
lysosomal cholesterol trafficking inhibits CSFV replication upstream of 
membrane fusion and RNA replication, suggesting virion trafficking 
through endolysosomal pathways after endocytosis (Liang et al., 2019). 
Accordingly, depletion of cellular cholesterol with methyl--
β-cyclodextrin does significantly inhibit CSFV infection, which can be 
reverted by exogenous addition of cholesterol, supporting the engage-
ment of cellular cholesterol in the CSFV life cycle (Yu et al., 2019). 
Following entry and uncoating, a defined sequence of events in the 
biosynthesis of the CSFV nonstructural proteins orchestrates Pestivirus 
replication (Lamp et al., 2011; Tautz et al., 2015). Self-replicating ge-
nomes (replicons) with gene deletions and reporter gene insertions were 
used in trans-complementation approaches to determine the minimal 
viral genome and cis-requirements of the viral proteins for genome 
replication (Behrens et al., 1998; Liang et al., 2009; Moser et al., 1999; 
Risager et al., 2013). This defined the 5-’ and 3′-UTRs and the replicase 
proteins NS3 to NS5B as the minimal Pestivirus replicon. The crystal 
structure of NS5B, the RdRP with the canonical GDD motif was solved 
for BVDV and more recently for CSFV (Choi et al., 2006; W. Li et al., 
2018a, 2018b). This latter study identified a novel fold in the N-terminal 
domain of CSFV NS5B, whose N-terminal and palm domain interact and 
modulate RdRP fidelity (W. Li et al., 2018a, 2018b; W. Liu et al., 2018a, 
2018b). The complex virus-host interactions that regulate CSFV repli-
cation were reviewed in (S. Li et al., 2017a, 2017b). Recently, it was 
shown that the ribosomal protein L13 is a critical regulator of 
IRES-driven translation, which is not specific to CSFV, as it was also 
observed for picornaviruses (Han et al., 2019). Also, for CSFV and BDV, 
the IIId2 sub-domains of the IRES are required for 80S ribosomes as-
sembly and IRES activity (Willcocks et al., 2017). The association of the 
eukaryotic translation initiation factor 3 subunit E with NS5A facilitates 
CSFV replication (X. Liu et al., 2018a, 2018b). The Golgi-specific bre-
feldin A-resistance guanine nucleotide exchange factor 1, as well as 
Rab2 and Rab5 were also associated with CSFV proliferation (Liang 
et al., 2017; J. Lin et al., 2017a, 2017b). 
Finally, apart from Npro and NS4B, all structural and nonstructural 
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proteins contribute to virion morphogenesis of pestiviruses (Dubrau 
et al., 2019; Klemens et al., 2015; Sheng et al., 2014), reviewed in 
(Fukuhara and Matsuura, 2019; S. Li et al., 2017a, 2017b; Tautz et al., 
2015; F.-I. Wang et al., 2015a, 2015b). However, the precise mecha-
nisms of virus assembly and budding remain poorly characterized. Little 
is known yet on the host’s proteins and organelles involved in 
morphogenesis. It was found that Annexin A2 is required for infectious 
particle formation (Sheng et al., 2015). Rab1A binds NS5A and is also 
involved in virion assembly (Lin et al., 2018). 
6.2. Host responses to CSFV infection 
Cells respond to invading pathogens by dysregulation of the cellular 
homeostasis, involving autophagy, apoptosis, necroptosis and pyropto-
sis, and by expression of antiviral proteins (reviewed in (Ma et al., 
2019)). These cellular responses are not necessarily antiviral. They can 
also be proviral. Autophagy is essential for sustained CSFV replication 
(Fan et al., 2020; Pei et al., 2014; Zhu et al., 2019). CSFV induces 
autophagy through the inhibition of mammalian target of rapamycin 
complex 1 (mTORC1) phosphorylation, which favours replication (Luo 
et al., 2018; Xie et al., 2020). As a negative feedback to the 
CSFV-induced mTORC1 hypophosphorylation, the 
phosphatidylinositol-3-kinase-/protein kinase B (Akt)/mTORC1 
pathway is activated, thereby maintaining an equilibrium between cell 
survival and viral replication (Luo et al., 2018). Autophagy induction 
through the inhibition of mTOR phosphorylation occurs in conjunction 
with NS5A-mediated induction of the calcium/calmodulin-dependent 
protein kinase kinase 2 - protein kinase AMP-activated catalytic sub-
unit alpha axis (Xie et al., 2020). Moreover, the induction of autophagy 
inhibits IFN-β induction through interaction between mitochondrial 
antiviral-signalling protein (MAVS) and beclin-1 (BECN1), which again 
favours CSFV replication (Xie et al., 2020). By means of NS5A, CSFV 
does also induce the canonical arms of the unfolded protein response 
involving the activating transcription factor 6, the inositol-requiring 
endonuclease 1 and the protein kinase R-like ER kinase, which is pro-
viral (Chengcheng et al., 2020; Zhu et al., 2019). This is consistent with 
the opposite observation that type I IFN-induced interferon-stimulated 
gene (ISG)15 upregulation promoted BECN1 ISGylation, which in turn 
inhibited autophagy and CSFV replication (C. Li et al., 2020a, 2020b, 
2020c). CSFV utilizes also mitochondrial fission and mitophagy to 
inhibit apoptosis, thus supporting cell survival and viral replication 
(Gou et al., 2017b; L. Zhang et al., 2018a, 2018b, 2018c). A recent study 
indicates that CSFV induces pyroptosis in monocytes, which may also 
play a role in supporting CSFV replication (Fan et al., 2018). CSFV 
infection activates caspase-1 thereby inducing the formation of the in-
flammatory complexes apoptosis-associated speck-like protein contain-
ing a CARD and NOD-, LRR- and pyrin domain-containing protein 3 to 
activate and release of IL-1β. In vivo, the situation is more complex and 
less studied. Autophagy, apoptosis, pyroptosis and T cell death following 
CSFV infection were also described in peripheral lymphoid organs (Gou 
et al., 2017a; J. Yuan et al., 2018a, 2018b). There, it may be associated 
with the characteristic lymphocyte depletion and immunosuppression 
associated with CSFV infection. 
The up-regulation of pro-inflammatory and IFN responses in a 
virulence-dependent manner is a hallmark of the host response to CSFV 
infection and is observed both, in vivo and in primary cells (reviewed in 
(Goraya et al., 2018; Summerfield and Ruggli, 2015)). This was 
described initially with RT-qPCR-based mRNA analysis of selected genes 
involved in the modulation of the host immune response in macrophages 
infected ex vivo with a virulent strain (Borca et al., 2008). The dysre-
gulated genes included pro-inflammatory cytokines, cytokine receptors, 
chemokines, IFNs, and toll-like receptors (TLR). Later, microarray 
analysis of PBMC collected before and at three consecutive days 
post-infection with either a highly or moderately virulent CSFV strain 
provided insights into the different virulence-dependent kinetics of 
cytokine and cell death/apoptosis-related ISG expression profiles 
(Renson et al., 2010). Studies of changes in the transcriptome in the 
tonsils of vaccinated and infected animals also highlight the involve-
ment of the ISG15 pathway in the host’s response to vaccination and 
infection (McCarthy et al., 2019). A recent field study confirmed 
pro-inflammatory cytokine expression after CSFV infection under nat-
ural conditions, while vaccination resulted essentially in elevated IFN-γ 
(Khatoon et al., 2019). Recently, porcine blood-derived conventional DC 
(cDC) 1, cDC2, pDC and monocyte subsets were identified by tran-
scriptional profiling using RNA sequencing of FACS-sorted subsets 
(Auray et al., 2016). Based on this, the same DC subsets were isolated 
from lymph nodes and tonsils from pigs at 18 and 42 h after infection 
with a high- and low-virulent CSFV and their activation was charac-
terized by unbiased transcriptomic analyses (Auray et al., 2020). 
High-virulent CSFV induced a stronger inflammatory and antiviral 
response but a weaker cell cycle response than the low-virulent virus. 
The high-virulent virus reduced also the antigen presentation functions 
of DC. These data provide high-resolution information on DC activation 
in pigs and information on how DC modulation may be linked to CSFV 
immunopathology. Several factors such as the pro-inflammatory allo-
graft inflammatory factor 1 modulate the cytokine responses (Gong 
et al., 2020). The potential role of pro-inflammatory responses in tissue 
damage and haemorrhages is not well understood. Recently, the upre-
gulation of the chemokine IL-8 in umbilical vein endothelial cells 
through NS4A-induced MAVS signalling was proposed to regulate the 
permeability of the endothelium (Dong et al., 2018). 
The cellular antiviral response is mediated essentially by ISGs. A 
recent RNAi screen revealed several ISGs with CSFV antiviral activities 
(Wang et al., 2016). The IFN-induced guanylate-binding protein 1 in-
hibits CSFV replication in a GTPase-dependent manner (Li et al., 2016). 
The IFN regulatory factor (IRF)1-mediated ISG15 induction following 
polyIC stimulation of porcine cell lines was also found to inhibit CSFV 
replication (X. Q. Li et al., 2018a, 2018b). There is also good evidence of 
antiviral activity of Mx proteins against CSFV in cell culture and ex vivo 
in cells from MxA transgenic pigs (D. N. He et al., 2014a, 2014b; X. 
Zhang et al., 2015a, 2015b; Zhao et al., 2016, 2011). It was shown 
recently that porcine Mx proteins exert their antiviral activity against 
CSFV by interacting with NS5B (Zhou et al., 2018). The antiviral activity 
of mouse Mx1 against CSFV relied on a mutation that favoured the 
cytoplasmic localization of Mx1 and interaction with the capsid protein 
C (Chen et al., 2020). Another recent study suggested that 
interferon-induced transmembrane protein (IFITM)1, 2 and 3 interfere 
with CSFV entry, and cell surface expression of IFITM1 decreased 
following infection (Li et al., 2019). The ISG Rsad2 (viperin) is upre-
gulated in response to CSFV infection and interacts with NS5A (C. Xu 
et al., 2020a, 2020b, 2020c). Rsad2 is also found in close vicinity of E2 
and NS5B and inhibits CSFV replication with a yet unknown mode of 
action (W. Li et al., 2017a, 2017b). CSFV can also trigger the innate 
antiviral responses and inhibit virus replication through activation of 
type III IFNs (Cai et al., 2017). Tumor necrosis factor (TNF) does also 
restrict CSFV replication. Pigs infected with CSFV induce significant 
levels of TNF (Choi et al., 2004; Khatoon et al., 2019; von Rosen et al., 
2013v; Wang et al., 2018), and TNF was reported to inhibit the repli-
cation of CSFV in vitro (Chen et al., 2019; Li et al., 2015). 
Cells also respond to invading pathogens with microRNA (miRNA) 
upregulation, which does typically modulate the cytokine responses at 
the mRNA level (Trobaugh and Klimstra, 2017). A genome differential 
miRNA and mRNA expression analysis in PBMC of pigs infected with a 
CSFV vaccine versus mock-vaccinated pigs identified miR-22–5p and 
miR-27b-5p upregulation (Sailo et al., 2019). Selected mRNA targets of 
these miRNAs, i.e. CD40, SWAP70, TLR4 and Lyn were modulated 
accordingly. 
6.3. Viral modulation of the antiviral host responses 
Viral proteins that are not essential for the basic life cycle of the virus 
have typically accessory functions such as modulation of the host innate 
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immune responses. However, modulation of host responses is not 
necessarily restricted to non-essential viral elements. CSFV controls the 
innate immune responses with the non-essential protein Npro and with 
the soluble form of the Erns protein (reviewed in (Summerfield and 
Ruggli, 2015), and possibly also through the sequestration of miR-17 
(Scheel et al., 2016). 
Npro is a two-domain protein with an N-terminal protease domain 
and a C-terminal domain carrying a Zn-binding TRASH motif, and the 
two domains contribute to its stability (Gottipati et al., 2016, 2014; Mine 
et al., 2015; Szymanski et al., 2009). The deletion of Npro does not 
abolish infectious particle formation but impairs virus replication in 
cells capable of producing type I IFN (Ruggli et al., 2003). Cells infected 
with CSFV are protected to some extent against dsRNA-induced 
apoptosis and necroptosis by inhibition of caspases activation, of mito-
chondrial apoptotic pathways and of type I IFN induction, which de-
pends on the presence of Npro (Itakura et al., 2020; Johns et al., 2010; 
Ruggli et al., 2003). Npro interacts directly with IRF3 monomers and 
dimers and mediates the proteasomal degradation of IRF3 indepen-
dently of its protease activity by yet unknown mechanisms, blocking 
efficiently type I IFN induction in non-pDC (Bauhofer et al., 2007; 
Gottipati et al., 2016; La Rocca et al., 2005; Ruggli et al., 2005). Inter-
estingly, a recent study showed that restoration of the Npro function in an 
Npro-defective conditionally cytopathogenic strain (GPE− ) prevented the 
induction of necroptosis but not of apoptosis, while an Npro-defective 
vALD-A76 mutant incapable of inhibiting type-I IFN production induced 
necroptosis and CPE (Itakura et al., 2020). Although Npro was charac-
terized essentially in cell culture, it is perfectly functional in vivo where it 
was shown to downregulate the local IFN-α mRNA expression in the 
infected tissues thereby contributing to viral pathogenicity (Tamura 
et al., 2014). In pDC, which are the main type I IFN producing cells in 
vivo and require IRF7 rather than IRF3 for type I IFN induction, Npro only 
partially dampens type I IFN induction by interacting with IRF7 without 
inducing its degradation (Fiebach et al., 2011). This may explain why 
CSFV induces IFN-α in vivo despite functional Npro, with levels that are 
proportional to the virulence of the isolate (Summerfield et al., 2006). 
Recently, Npro was also found to suppress IRF1-mediated IFN-λ pro-
duction by inhibiting IRF1 expression and its nuclear translocation (T. 
Cao et al., 2019a). 
The second CSFV protein known to date to impair host type I IFN 
induction is the soluble form of the structural Erns protein, a function 
that depends on its RNase activity (Python et al., 2013), reviewed in 
(Summerfield and Ruggli, 2015). The biochemical mechanisms by 
which Erns interferes with type I IFN induction through dsRNA degra-
dation were dissected in vitro for BVDV Erns (Lussi et al., 2018; Mag-
kouras et al., 2008; Mätzener et al., 2009; Zurcher et al., 2014). Erns is 
supposed to function in a similar way for the two pestiviruses, with, 
however, different consequences in the pathogenesis of the associated 
disease, i.e. CSF versus persistent BVD/Mucosal disease (for extensive 
reviews, see (Lussi and Schweizer, 2016; Summerfield and Ruggli, 
2015)). Besides its membrane-anchored and virion-associated form, a 
minor fraction of the protein is secreted from infected cells (Burrack 
et al., 2012; Fetzer et al., 2005). Erns-mediated inhibition of type I IFN 
induction through extracellular targeting and degradation of dsRNA by 
Erns was shown in vitro (Iqbal et al., 2004; Luo et al., 2009; Magkouras 
et al., 2008; Mätzener et al., 2009), but evidence for Erns activity in 
extracellular compartments in vivo is lacking. Erns is more likely to 
function in endocytic compartments (reviewed in (Lussi and Schweizer, 
2016)). Indeed, Erns can be rapidly endocytosed and degrades endo-
somal RNA in cell lines and porcine pDC (Python et al., 2013; Zurcher 
et al., 2014). Interestingly, similar to observations with HCV (Takahashi 
et al., 2010), CSFV-infected porcine macrophages or cell lines stimulated 
pDC for IFN-α production (Python et al., 2013). Importantly, cells 
transduced with CSFV replicons lacking Erns expression were signifi-
cantly more potent at stimulating pDC than virus-infected cells, sug-
gesting a virion-free transfer of a viral RNA trigger to pDC as for HCV, 
but in addition, an inhibitory role of Erns. This was eventually 
demonstrated to be dependent on RNase-active Erns by reconstitution of 
functional Erns in trans, which significantly reduced the 
replicon-mediated pDC activation as opposed to the RNase-inactive Erns 
(Python et al., 2013). The relevance of these mechanisms remains to be 
demonstrated in vivo. 
In addition to Npro and Erns, there is evidence from lentiviral 
expression experiments in monocyte-derived macrophages (MDMs) that 
the nonstructural proteins NS2 to NS5A may also modulate the TLR 
pathways (Z. Cao et al., 2019). However, these data need further vali-
dation in the virus context. Also, unbiased differential transcriptome 
analyses in porcine alveolar macrophages infected ex vivo with CSFV 
showed an increase of p53 and p21 expression and a decrease of cyclin 
E1 and CDK2, leading to cell cycle arrest at the G1 phase (Ning et al., 
2017). How CSFV modulates the host cell and whether this supports 
replication requires further investigation. 
Pestivirus replication depends strongly on miR-17 and let-7 binding 
(Scheel et al., 2016). Consequently, viral sequestration of miR-17 results 
in dysregulation of cellular transcripts harbouring miR-17 binding sites, 
which was confirmed at the protein level. Unbiased transcriptomic an-
alyses of MDMs infected ex vivo with CSFV revealed a significant 
time-dependent upregulation of cellular transcripts harbouring a 
miR-17 binding sequence in the 3′-UTR (Scheel et al., 2016). There are 
also several lines of evidence that miRNA modulates CSFV replication 
indirectly through the regulation of host factor expression. CSFV 
downregulates miR-140, a negative regulator of Rab25 that supports 
CSFV replication (P. Xu et al., 2020a, 2020b, 2020c). It can be debated 
whether this is a countermeasure of the virus to counteract the 
host-mediated miR-140-dependent downregulation of the pro-viral 
Rab25. 
7. Viral determinants of virulence 
CSFV isolates cover a broad range of virulence, as witnessed for 
example by analysis of the virulence of CSFV isolated in Europe between 
1996 and 2007 (Floegel-Niesmann et al., 2009a, 2003). Other examples 
are a comparative study of CSFV of different virulence in terms of 
pathogenicity, tissue distribution and immunohistochemistry (Belák 
et al., 2008), and virulence studies with genotype 2.3 isolates in wild 
boar (Kaden et al., 2004). 
Here we define virulence of CSFV as the ability of a given virus – field 
isolate, laboratory strain or cDNA derived-virus – to cause clinical signs 
and pathological damage in pigs, which is often also be referred to as 
pathogenicity. Strictly taken, however, the definition of the degree of 
virulence of a given CSFV is associated with defined host conditions. A 
virus for which virulence was defined under specific conditions may 
manifest with different degrees of pathogenicity depending on host 
factors such as age, breed, genetic background, hygiene and immuno-
logical status. Therefore, in this review, we distinguish between viral 
determinants of virulence and viral elements and host factors that 
modulate virulence. The numerous mechanisms by which virus-host 
interactions modulate virulence and influence the pathogenicity of a 
virus in the field or in experimental infections were described in the 
previous chapters. Different experimental approaches to define the viral 
genetic basis of virulence were reviewed extensively in (Leifer et al., 
2013). 
7.1. The non-essential protein Npro 
In the sense of what we defined above, the main viral element that 
modulates virulence without being considered a virulence determinant 
per se is the non-essential protein Npro. This can be illustrated with the 
following studies. When the Npro gene of the highly virulent Eystrup 
strain was replaced with that of the live attenuated vaccine strain Riems, 
the virulence of the chimeric Eystrup virus remained unchanged, while 
the deletion of Npro from the high-virulent Eystrup or the moderately 
Alfort/187 backbone attenuated the viruses (Mayer et al., 2004). 
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Second, with highly virulent isolates, mutations that abrogate the IRF3 
degrading function of Npro did not reduce the virulence of the Eystrup 
strain and partially reduced virulence of the less virulent Alfort/187 
virus (Ruggli et al., 2009). Thus, the same mutation of Npro modulates 
virulence to a different degree, depending on the viral virulence de-
terminants that differ between Eystrup and Alfort/187. A follow-up 
study showed that Npro contributes to virulence in a sense that it is 
essential for the full functionality of the virus to inhibit type I IFN in-
duction at local replication sites in different organs in vivo (Tamura 
et al., 2014). The localization of Npro in the nucleus was also related to 
virulence with yet unknown mechanisms (Y. Li et al., 2014a, 2014b). 
7.2. Loss- versus gain-of-function approaches to identify virulence 
determinants 
In analogy to Npro, the different Erns features, i.e. its integration in the 
virion membrane and its RNase activity in soluble form as well as its 
dimerization are essential for the full functionality of the virus in vivo, 
and therefore knocking out these functions modulates virulence without 
strictly representing virulence determinants. Mutations inactivating the 
RNase activity or preventing Erns homodimer formation by disruption of 
the intermolecular cysteine bond (Cys-171) attenuate the virus in pigs 
(Meyers et al., 1999; Tews et al., 2009). Reversion of Erns dimerization 
by a spontaneous compensatory mutation in vivo restored virulence, 
confirming the importance of Erns dimer formation for CSFV virulence 
(Tucakov et al., 2018). The report showing that functional Npro and Erns 
are essential for persistent transplacental infection with BVDV support 
the importance of these two proteins for pestiviruses to express their full 
virulence and pathogenic potential (Meyers et al., 2007). Interestingly, 
the repeated amplification of CSFV in permanent cell lines by which the 
virus acquires increased affinity to cellular HS is associated with mu-
tations in Erns and loss of virulence in vivo (Eymann-Häni et al., 2011; 
Hulst et al., 2001; van Gennip et al., 2004v). For all three structural 
glycoproteins, numerous reports demonstrate that knocking out glyco-
sylation sites affects virulence (for selected references, see (Fernan-
dez-Sainz et al., 2009; Risatti et al., 2007; Sainz et al., 2008)). Other 
mutations that modify virulence were described in the envelope proteins 
(Risatti et al., 2006, 2005a, 2005b; van Gennip et al., 2004v) or in 
combination with changes in the nonstructural proteins (Tamura et al., 
2012; van Gennip et al., 2004v). Alteration of the E1-E2 hetero-
dimerization and mutations in NS4B did also affect virulence (Fernan-
dez-Sainz et al., 2011, 2010). Cytopathogenicity of CSFV correlated also 
with attenuation (Gallei et al., 2008). Recently, it was suggested that E2 
and the 3′-UTR affect virulence synergistically (Wu et al., 2017). All 
these latter reports rely on targeted loss-of-function studies using reverse 
genetics. A different approach consisting of the analysis of CSFV evo-
lution under different conditions revealed positive selection-driven al-
terations of the glycoprotein structures and glycosylation or of the 
haplotype composition of the virus, which was in part correlated with 
virulence (Fahnøe et al., 2019; Tang et al., 2008; Wu et al., 2010). 
Cloning and analysis of full-length genetic haplotypes revealed inter-
esting features of viral genome requirements for virulence (Fahnøe et al., 
2015, 2014). As opposed to previous studies, we used reverse genetics 
with a gain-of-function approach to demonstrate a synergistic effect of 
the envelope glycoprotein E2 and the nonstructural protein NS4B in 
determining virulence (Tamura et al., 2012). This latter study built on 
forward genetics data from vaccine virus mutants that had recovered 
virulence upon artificial serial passages in pigs. By applying reverse 
genetics, the mutations acquired were reintroduced in the vaccine 
backbone and the resulting phenotype was determined in pigs. A com-
bination of amino acid mutations in the envelope protein E2 and in the 
N-terminus of NS4B enhanced virulence. The virulence of this latter 
mutant was further increased by substitution of the N-terminal domain 
of NS4B with that of the highly virulent Eystrup strain, which resulted in 
changes in ER membrane association of NS4B and increased replicase 
activity (Tamura et al., 2015). Forward genetic studies with field isolates 
from Cuba that evolved under positive selection pressure resulting from 
suboptimal vaccination did also suggest a role of E2 for virulence (Pérez 
et al., 2012). The loss of virulence of these field isolates was associated 
with an antigenic drift in the major immunogenic epitopes of E2 
(Coronado et al., 2019b). However, gain-of-function experiments using 
reverse genetics are required to determine formally the role of these E2 
mutations for virulence. Very recently, with such an approach we have 
demonstrated the role for virulence in newborn piglets of a novel 
poly-uridine sequence in the 3′-UTR acquired by one of these latter field 
isolates in Cuba (Coronado et al., 2017; Wang et al., 2019). 
8. Diagnosis 
Rapid clinical diagnosis is of particular importance as the first line of 
defence for the detection and control of primary CSF outbreaks 
(Moennig et al., 2003; Moennig and Becher, 2015). The evolution to-
wards moderately or low virulent strains that do not cause typical signs 
of disease and spread slowly within a herd has resulted in longer 
high-risk periods facilitating unnoticed spread of CSF between farms. 
Several other viral diseases such as African swine fever, porcine respi-
ratory and reproductive syndrome, porcine dermatitis and nephropathy 
syndrome, post-weaning multisystemic wasting syndrome as well as 
infections with various bacteria causing septicaemia may be confused 
with CSF; these bacterial infections include erysipelas, salmonellosis, 
pasteurellosis, actinobacillosis, eperythrozoonosis, and infections with 
Haemophilus parasuis. Therefore, the variability of clinical signs and post 
mortem lesions does not allow unequivocal diagnosis of CSF (Blome 
et al., 2017b; OIE, 2019d; Postel et al., 2018). Even typical clinical signs 
or post mortem lesions can only lead to a suspicion of CSF and any 
tentative diagnosis must be confirmed by laboratory diagnosis. Methods 
for detection of CSFV antigen and nucleic acid as well as CSF-specific 
antibodies are described in the OIE Manual of Diagnostic Tests and 
Vaccines for Terrestrial Animals, 2019 and in the CSF Diagnostic Manual 
2002/106/EC Technical Annex which has been recently updated 
(Anonymous, 2020; OIE, 2019d). A high-quality laboratory diagnosis is 
a prerequisite for rapid detection and efficient control of CSF. For each 
method used in different laboratories for CSF diagnosis, specificity, 
sensitivity and other quality parameters are evaluated on a regular basis 
to ensure a high-quality standard. For the National Reference Labora-
tories for CSF in the European Union, participation in an 
inter-laboratory comparison test is obligatory and represents an efficient 
and important tool to maintain a high standard of CSF diagnosis (Floe-
gel-Niesmann et al., 2009b). 
8.1. Detection of virus, viral antigen, and viral nucleic acid 
For virus isolation and detection of viral antigen or viral genomic 
RNA, anticoagulated blood samples and body fluids from live animals, as 
well as tonsils, spleen, lymph nodes, thymus, intestine, kidney, lung, and 
other organ samples from dead animals, can be used. Swab samples from 
both, live and dead domestic pigs and wild boar, are also suited for 
detection of CSFV (Petrov et al., 2014b; Postel et al., 2018). CSFV can be 
easily grown in various porcine tissue cultures. Therefore, virus isolation 
represents a classical method for CSFV diagnosis, which is used routinely 
in many laboratories. The porcine kidney cell lines PK15 and SK6, as 
well as a swine testis endothelial (STE) cell line, are particularly suited 
for CSF diagnosis (Anonymous, 2020). PK15 cells can be contaminated 
with porcine circovirus-1 (Tischer et al., 1982). For CSF diagnosis, it is 
recommended to use circovirus-free PK15 cells. Porcine cells are, at least 
to some extent, susceptible to BVDV and other ruminant pestiviruses 
whose presence can significantly interfere with CSF diagnosis. Accord-
ingly, it is important to demonstrate the absence of BVDV and other 
ruminant pestiviruses in all cell lines used for CSF diagnosis. STE, PK15, 
and SK6 cells can be adapted to grow in medium supplemented with 
horse serum instead of fetal calf serum, thereby minimizing the risk of a 
contamination with BVDV and other ruminant pestiviruses 
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(Anonymous, 2020). With a very few exceptions, the vast majority of 
CSFV isolates are noncytopathogenic and do not cause visible effects in 
cell culture (Gallei et al., 2008, 2005; Kosmidou et al., 1998). Conse-
quently, after infection of cells with CSFV, the presence of viral antigen 
has to be visualized by immunological reactions including immuno-
peroxidase or immunofluorescence staining. Monoclonal antibodies 
directed against CSFV-specific epitopes have replaced antisera obtained 
after immunisation of animals with the infectious virus or with geneti-
cally engineered CSFV antigens. In addition to the detection of viral 
antigen after virus isolation and propagation in tissue culture cells, CSFV 
antigen can be detected directly in cryo-sections of organs from infected 
animals by fluorescence Ab test (FAT). In many laboratories, the FAT 
was replaced by more sensitive molecular diagnostics, e.g. reverse 
transcription and PCR (RT-PCR). 
In the late 1980s, the first prototype CSFV antigen enzyme-linked 
immunosorbent assays (ELISAs) were developed and used for the diag-
nosis of CSF. The sensitivity and in particular the specificity can vary 
among different ELISA setups and have to be thoroughly evaluated. The 
CSFV antigen ELISAs detect typically the viral glycoprotein Erns. In 
general, antigen ELISAs are suited for monitoring CSF at farm or pop-
ulation level but are not suited to demonstrate absence of CSFV in in-
dividual animals. Moreover, in case of a primary CSF outbreak, it is 
recommended to confirm a positive ELISA result by virus isolation in cell 
culture or detection of viral nucleic acid by RT-PCR (see below); such a 
confirmation is obligatory in the European Union and many other parts 
of the world. 
In the 1990s, detection of viral genomic RNA by RT-PCR was added 
to the repertoire of methods routinely used in CSF diagnosis (Díaz de 
Arce et al., 1998; Katz et al., 1993; Vilček et al., 1994). Both, 
CSFV-specific and pan-pestivirus RT-PCRs – the latter detecting a broad 
range of pestiviruses including CSFV – have been established. For 
broadly reactive RT-PCRs, subsequent nucleotide sequencing of the 
amplified nucleic acid is essential for CSF diagnosis. The conventional 
gel-based RT-PCRs were replaced by various highly sensitive and rapid 
real-time quantitative RT-PCR (qRT-PCR) methods, which no longer 
need gel electrophoresis to visualize amplified nucleic acids (Anony-
mous, 2020; Hoffmann et al., 2005; Leifer et al., 2011; McGoldrick et al., 
1999; OIE, 2019d; Postel et al., 2012). Today, qRT-PCR is the method of 
choice for rapid and highly sensitive CSF diagnosis. Several in-house 
methods and commercial kits are available which target different re-
gions in the CSFV genome. In an ideal world, the available RT-PCR kits 
detect all CSFV isolates but do not detect any other Pestivirus. For reli-
able and solid diagnosis of CSF by qRT-PCR, the increasing genetic 
variability of CSFV has to be taken into account and the individual test 
methods must be evaluated thoroughly by investigating recent CSFV 
isolates on a regular basis. In case of a test failure, the sequence(s) of the 
primer(s) used for amplification in the PCR reaction must be adapted to 
cover the increased spectrum of CSFV variants. One example for such a 
test failure was the lack of detection of a CSFV 2.1 isolate from Israel by a 
widely used commercial qRT-PCR kit (David et al., 2011); subsequent 
analysis of the nucleotide sequence targeted by the primers and adap-
tation of primer sequences solved the problem. This example illustrates 
the necessity to monitor continuously the genetic variability of 
re-emerging CSFV isolates and to re-evaluate the reliability of qRT-PCR 
and other available test methods by analysis of recently evolved virus 
variants. 
8.2. Detection of CSFV-specific antibodies 
Approximately 10–14 days after infection with CSFV, the first anti-
bodies can be detected in most animals (Moennig et al., 2013). In-
fections with BVDV, BDV and other closely related ruminant pestiviruses 
may induce cross-reacting antibodies interfering with CSF diagnosis 
(Avalos-Ramirez et al., 2001; Becher et al., 2003; Darbyshire, 1960; 
Dekker et al., 1995; Postel et al., 2015). A recent study demonstrated 
that the distantly related APPV does not interfere with CSF diagnosis 
(Postel et al., 2017a). Nevertheless, cross-reactive antibodies, in 
particular those induced by infection with BDV, are a major challenge in 
serological diagnosis of CSF. 
For Ab detection, serum samples as well as body fluids, for instance 
from shot wild boar, can be investigated by virus neutralization test 
(VNT) and CSFV Ab ELISA (Moennig and Becher, 2015). Due to its high 
sensitivity and high specificity, the VNT represents the gold standard for 
Ab detection. It is based on the ability of neutralizing antibodies to 
inhibit virus infection. Accordingly, the VNT requires appropriate tissue 
culture cells to propagate infectious CSFV and a laboratory infrastruc-
ture with permission to handle the virus. This method is laborious and 
not suited for analysis of a large number of samples. Assays that allow 
serological multiplexing (e.g. by microsphere technology) or that use 
genetically modified, fluorescence-labelled test viruses may facilitate 
the serological differentiation of Pestivirus-induced antibodies, but are 
not widely established yet (Li et al., 2013; Tetsuo et al., 2020; Xia et al., 
2015). An advantage of the VNT compared to conventional ELISA is its 
potential to discriminate CSFV-specific antibodies from antibodies 
resulting from infections with BVDV, BDV and other ruminant pestivi-
ruses. Thus, VNT is the most important tool to follow up questionable or 
positive results obtained in Ab ELISAs and to determine whether these 
antibodies are induced by CSFV or non-CSFV pestivirus infection. 
Importantly, with the VNT, the capacity to determine the specificity of 
serum antibodies is highly dependent on the selection of an appropriate 
panel of test strains routinely used in the laboratory as well as the 
knowledge of which pestiviruses are circulating in the field. 
CSFV Ab ELISAs detect antibodies against the glycoproteins Erns and 
E2. ELISAs have the advantage that a large number of samples can be 
investigated in a short time, underlining their suitability for CSF sur-
veillance, in particular to confirm a CSF-free status at the herd level 
(Moennig and Becher, 2015). In addition to E2-based Ab ELISAs, several 
Erns Ab detection assays have been developed (Aebischer et al., 2013; Lin 
et al., 2005; Luo et al., 2015; Meyer et al., 2017). The Erns double-antigen 
ELISA (dELISA) is particularly suited for highly sensitive and specific Ab 
detection thanks to fewer problems with cross-reactive Abs than most 
indirect ELISAs (iELISA) and a sensitivity comparable to competitive 
ELISAs (cELISA) without requiring a competing monoclonal Ab. The 
first Erns dELISA developed allowed detection of Abs already at early 
time points after infection and showed high specificity even with sam-
ples derived from wild boar that are often problematic in serological 
tests (Meyer et al., 2017). Design and optimization of tests targeting 
Erns-specific Abs is of particular interest in the context of CSF marker 
vaccines that are able to induce neutralizing E2-specific Abs in absence 
of a CSFV Erns-specific Ab response (Meyer et al., 2018; Pannhorst et al., 
2015; Schroeder et al., 2012). The reliable discrimination between 
infected and vaccinated animals (DIVA) remains a major challenge in 
serological diagnosis of CSF. A robust DIVA test is an important pre-
requisite for the implementation of control strategies based on emer-
gency vaccination with marker vaccines. 
9. Recent progress on CSF vaccines 
Vaccination strategies against CSF depend on the epidemiology of 
the disease, on the animals affected – domestic pigs and/or wild boar – 
and on the economic situation, resulting in different requirements for 
the vaccines to be applied. For example, in endemic regions with do-
mestic pigs and with little international trade, the priority is to protect 
against losses due to clinical disease. Such regions require safe, effective 
vaccines that are economical, easy to apply and give long-lasting im-
munity. In CSFV-free areas and where international trade in domestic 
pigs is important, emergency vaccination strategies that rapidly contain 
disease spread are important. This requires fast-acting vaccines, ideally 
with DIVA capacity, to minimise the impact on trade. Such DIVA vac-
cines are also desirable to assist in eradication programmes. The situa-
tion is different when vaccines are needed to control the virus in wild 
suidae populations. This requires a vaccine for oral application that 
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provides long-lasting immunity with a single dose, which ideally has 
DIVA capacity to monitor the progress of vaccination campaigns. 
Live attenuated vaccines are widely used to control CSF disease in 
many areas and have paved the way to successful eradications, but these 
vaccines have the disadvantage that they lack DIVA. Two marker sub-
unit DIVA vaccines, Porcilis Pesti (MSD Animal Health) and BayoVac 
(BAYER AG), both based on the immunogenic E2 protein expressed in 
baculovirus systems were developed (van Oirschot, 2003v). These vac-
cines, for which the DIVA principle relies on the detection of antibodies 
directed against the CSFV Erns protein to identify infection with field 
virus, protect against disease. However, their efficacy is lower than the 
live attenuated vaccines, with a later onset of immunity, incomplete 
protection against vertical transmission, and the requirement for a 
two-dose inoculation regime. In addition, the early accompanying DIVA 
tests lacked sensitivity and these vaccines are also not compatible with 
oral delivery to wildlife (van Oirschot, 2003v). Due to these limitations 
research strove towards a second generation of marker vaccines. 
Extensive efforts within a multi-partner collaboration lead to the li-
cencing by the European medicine agency of a novel CSF marker vac-
cine, Suvaxyn, in 2014 (Blome et al., 2017c). This vaccine, also referred 
to as CP7_E2Alf, is a chimeric pestivirus constructed in a BVDV virus 
backbone in which the E2 gene is replaced by the E2 gene from the CSFV 
strain Alfort/187. This vaccine is safe and as efficacious as the classical 
live attenuated vaccines but with the added benefit of DIVA capability. 
Also, it is possible to formulate this vaccine for oral delivery to be 
applied in wild boar. A drawback with this vaccine is the cross-reactivity 
observed with sera from BDV- and BVDV-infected animals in the Erns 
based differential ELISAs (Blome et al., 2017c). Reduced specificity was 
also observed in animals with maternally-derived antibodies and whilst 
DIVA differentiation is possible these factors complicate serological 
surveillance (Meyer et al., 2018). In addition, there was only partial 
protection against vertical transmission after early challenge with highly 
virulent strains. The licencing of this vaccine on the European market 
came at a time when CSF was no longer reported in the region, thanks to 
the long efforts to eliminate the disease from domestic and wild pig 
populations. Therefore, there has been limited need to apply this vac-
cine, and hence the benefits of its use to contain disease with minimal 
impact on trade with international partners, compared to a stamping-out 
policy, is yet to be demonstrated by extensive application in the field 
(Blome et al., 2017b). 
9.1. Improving live attenuated (non-DIVA) vaccines and their application 
Among the many live attenuated CSF vaccines developed, the C- 
strain is the most widely used and can prevent 100 % of CSF clinical 
signs, regardless of the genotype of the challenge strain (Aynaud and 
Launais, 1978; Graham et al., 2012a, 2012b, Suradhat and Dam-
rongwatanapokin, 2003; Vandeputte et al., 2001). However, the virus 
can persist even in areas where vaccination with these highly effective 
vaccines is mandatory (Coronado et al., 2019a; Zhou, 2019). Various 
reasons contribute to the ongoing circulation of the virus in vaccinated 
populations, one of which is the ineffective application of vaccines in the 
field. Both, the cost of vaccines and ease of application are barriers that 
can contribute to lowering effective vaccine coverage, particularly in 
resource-poor settings (Coronado et al., 2017). Additionally, the 
inability to maintain the cold chain can affect the conservation of the 
vaccine in field situations. To understand the continued circulation of 
CSFV in endemic areas under vaccination, viral evolution studies have 
been conducted. Several reports described the possible emergence of 
new CSFV strains because of a positive selection pressure (positively 
selected strains). This evolutionary force resulted from a “bottleneck” 
effect due to the indiscriminate and mishandled use of conventional 
vaccines (Coronado et al., 2017; Hu et al., 2016; Jang et al., 2020; Ji 
et al., 2014; Luo et al., 2017; Pérez et al., 2012; Rios et al., 2017; Shen 
et al., 2011). Several authors have reported that prolonged suboptimal 
vaccination programs may have caused changes in the pathogenicity 
and antigenicity of the new emerging strains that could potentially 
escape vaccination (Coronado et al., 2019b, 2017; Hu et al., 2016; Jang 
et al., 2020; Ji et al., 2014; Shen et al., 2011). This may favour the high 
prevalence of chronic and persistent CSF, leading to unsuccessful control 
of the disease. Efforts that facilitate the implementation of optimal 
vaccination programs with live attenuated vaccines are therefore 
beneficial. 
Many C-strain variants are produced in different countries. Unfor-
tunately, some countries still produce the vaccines in rabbits and efforts 
to produce vaccines in cell culture are encouraged. Good cell culture- 
adapted vaccines, such as the Riems strain used in the EU for wild 
boar vaccinations, exist but some lapinised versions of C-strain grow 
poorly in cell culture leading to poor productivity. Sequencing of cell 
culture passaged C-strain, identified eight amino acid mutations which, 
when re-introduced into the parental virus by genetic modification, 
resulted in a genetically stable virus with enhanced growth. This virus 
retained the ability to protect pigs from challenge at 4 weeks post- 
vaccination (T. Cao et al., 2019b). Knowledge on such changes that 
can increase virus replication and enhance efficient production, and 
hence reduce costs of high-quality live vaccines, has the potential to 
benefit effective vaccine application. The current commercial oral bait 
vaccine contains liquid C-strain vaccine within corn-covered blister 
packs and requires storage at − 20 ◦C, which limits its use in remote 
regions with warmer climates. In addition, the cost of the commercially 
formulated baits could be a factor against effective deployment in some 
sectors. Vaccine baits, prepared by absorption of C-strain onto bread and 
subsequent lyophilisation, were stable for 18 months at 4 ◦C and pigs 
consuming these vaccine baits seroconverted after 14 days (Kunu et al., 
2019). Whilst still requiring some form of cold storage, 4 ◦C is more 
feasible to achieve than − 20 ◦C, and this could provide a more 
cost-effective method to improve vaccination in these hard to reach pig 
populations. 
9.2. Developments in live attenuated DIVA vaccines 
During development of the CP7_E2Alf vaccine, studies to assess 
protection from vertical transmission used early challenge with a highly 
virulent virus (Henke et al., 2018). Under these stringent conditions, 
which were aimed at testing the early protective capacity of this vaccine 
in an emergency situation, some animals were not protected from ver-
tical transmission. This led to the inclusion of a warning in the summary 
of product characteristics, stating that sows should not be vaccinated 
due to the risk of birth of persistently-infected offspring (EMA, 2019). 
Nevertheless, the CP7_E2 Alf vaccine protected against experimental 
challenge with a moderately virulent strain representative of currently 
circulating viruses, 3 weeks post-vaccination, indicating a low risk of 
undetected persistently infected offspring arising (Henke et al., 2018). 
A promising vaccine candidate has been developed by genetic 
elimination of a highly conserved CSFV-specific epitope of the E2 
glycoprotein and the inclusion of a Flag epitope in E1 as a positive 
marker (Holinka et al., 2014). This virus induces effective immunity 
against challenge as early as 3 days after vaccination (Holinka et al., 
2017). DIVA tests relying on the positive and negative antigenic markers 
of this vaccine candidate remain to be developed. 
Another live attenuated chimeric DIVA vaccine, Flc-LOM-BErns, has 
been described recently and is applied in South Korea (Lim et al., 2019). 
The Flc-LOM-BErns vaccine is based on an infectious clone of the LOM 
(low virulence of Miyagi) vaccine strain in which the 3′-end of the capsid 
gene and the full Erns gene were replaced with the equivalent sequences 
from a BVDV-1 virus. DIVA capacity is therefore possible with the 
Flc-LOM-BErns vaccine, with detection of antibodies against CSFV Erns 
being indicative of a field virus infection. This vaccine protects against 
vertical transmission: no virus was detected in fetuses from sows 
vaccinated 3 weeks before insemination and challenged at three 
different stages during pregnancy. This vaccine promises to provide an 
improved vaccination option in South Korea compared to the currently 
L. Ganges et al.                                                                                                                                                                                                                                  
Virus Research 289 (2020) 198151
13
used parental LOM vaccine strain, which can cause abortion and still-
birth in pregnant sows (Choe et al., 2019). Vaccination with the 
LOM-BErns vaccine started in South Korea in 2020 and use under field 
conditions will provide valuable data on the safety of the vaccine and the 
robustness of the DIVA concept. 
9.3. Recent developments in viral vector CSFV vaccines 
Like chimeric pestiviruses, the use of viral vectors to deliver CSFV 
antigens can retain the advantages that live vaccines have over subunit 
vaccines by targeting multiple aspects of the immune response to pro-
vide greater efficacy. A number of recent studies have continued in-
vestigations into the use of viral vectors as candidate DIVA vaccines. 
Constructs expressing the CSFV E2 and Erns proteins in a Newcastle 
disease vaccine (NDV) strain have been produced (Kumar et al., 2019). 
NDV has advantages as a delivery vector in that it can grow to high titres 
in embryonated eggs and in cell cultures, which allows cost-effective 
vaccine production. The vector is also able to infect via the intranasal 
route, thereby targeting induction of responses at the primary site of 
CSFV entry and replication. Another interesting study has investigated 
the use of recombinant baculovirus vectors as a vehicle to deliver DNA 
encoding CSFV E2 in pigs (Liu et al., 2017). 
A recombinant swine pox virus construct rSPV-E2, expressing the E2 
protein, has also been produced (H. Lin et al., 2017a, 2017b). Like other 
poxviruses, the swinepox virus can encode large amounts of recombi-
nant proteins and is a potent stimulator of both, cellular and humoral 
immunity. Pigs immunised intramuscularly with two doses of the 
rSPV-E2 candidate were clinically protected against CSFV challenge and 
only very low levels of CSF viral RNA were detected in serum shortly 
after challenge, indicating the potential for this construct to also protect 
against transmission, although further work would be needed to 
demonstrate this. Advantages of this system include the potential to 
construct a multivalent vaccine incorporating antigens against other 
porcine viruses, and the potential for skin prick subcutaneous delivery 
(X. Yuan et al., 2018a, 2018b). As with all novel viral vectors for vac-
cines based on viruses that infect and cause even mild disease in the 
porcine host, adequate attenuation and safety of the viral vector, as well 
as lack of interference due to pre-existing immunity to the vector, needs 
to be demonstrated. 
One of the most promising viral vector/replicon CSF vaccine candi-
dates is the adenovirus/alphavirus replicon based vaccine, rAdV-SFV- 
E2, which uses the replication-defective Ad5 vector to deliver a Sem-
liki Forest virus replicon to express the E2 gene. Comprehensive studies 
with this candidate were reviewed previously, and this vaccine is under 
investigation for use in eradication campaigns in China (Blome et al., 
2017a). Since that review, the efficacy of using a 2-dose regime of this 
vaccine in animals with MDA, derived either from vaccination with 
C-strain or rAdV-SFV-E2, was confirmed (Xia et al., 2016): Piglets with 
MDA vaccinated at 4 weeks of age, and boosted after 3 weeks, were 
completely protected against subsequent challenge with virulent CSFV. 
The lack of expression of the E2 protein until after delivery of the vector 
to cells, and lack of induction of antibodies to the Ad5 vector, may ac-
count for this absence of MDA interference and is a significant benefit of 
this rAdV-SFV-E2 vaccine candidate. 
With the aim of developing vaccines protective against multiple pig 
diseases, various studies have reported the construction and testing of 
existing porcine vaccine strains manipulated to express antigens from 
additional pathogens (Abid et al., 2019; Gao et al., 2018; Lei et al., 2016; 
Tong et al., 2020; Y. Wang et al., 2015a, 2015b; Zhang et al., 2017). 
9.4. Improved E2 subunit vaccines 
A baculovirus-expressed E2 vaccine, similar to the previously li-
cenced subunit E2 vaccines but based on a local genotype 1.1 CSFV 
isolate VN91 from Vietnam, protected against clinical disease, using a 2- 
dose regime. The challenge viruses were local genotype 1.1, 2.1 and 2.2 
CSFV isolates. Neither challenge virus nor viral RNA were detected in 
the spleens of vaccinated animals, supporting the suitability of the 
vaccine for further development (Tran et al., 2020). To improve 
cost-effective production of secreted protein from baculovirus-infected 
insect cells, a signal sequence from the E2 protein of the CSFV isolate 
ZJ from Zhejiang was used (H. Xu et al., 2020a, 2020b, 2020c). The E2 
from this ZJ strain also appeared to have some enhanced immunoge-
nicity and clinical protection was observed after a single immunisation 
of pigs with a low dose of only 5 μg of protein. CSFV antigen was not 
detected by immunohistochemistry in animals vaccinated with this 
single low dose but no PCR nor virus isolation data were presented. A 
further baculovirus-expressed E2 subunit vaccine, based on the E2 from 
the C strain, has been developed and commercialised (Gong et al., 
2019). A prime-boost vaccination with this Tian Wen Jing (TWJ-E2®) 
vaccine, which was licenced for use in China in 2018, protects against 
challenge with virulent genotype 2 strains currently circulating in 
China. Only background levels of viral RNA were detected in blood, 
tissues or swabs indicating a good potential to protect against trans-
mission, but the level of protection in pregnant sows against trans-
placental transmission remains to be established. 
The use of E2 expressed in plants has been examined as a method to 
provide cost-effective protein production. Plants don’t require special-
ized facilities and production can be easily scaled up. E2 produced in 
transgenic Arabidopsis thaliana (cress) plants was immunogenic in mice 
and could be recognized by CSFV-specific antibodies (Sohn et al., 2018). 
Nicotiana benthamiana plants produce higher amounts of biomass than 
Arabidopsis. Dimeric E2, produced in N. benthamiana and formulated 
with different adjuvants, has been assessed for protection against CSFV 
challenge 35 days after either a single or a double dose (Laughlin et al., 
2019; Park et al., 2019). Whilst the efficacy of a single dose regime with 
plant-derived E2 to provide adequate protection against horizontal and 
transplacental transmission is yet to be demonstrated, the lower pro-
duction costs offered are encouraging and offer the potential for a 
cost-effective increase in the antigen concentration in a single dose, 
which may enhance vaccine efficacy. Recent studies have investigated 
the dose required, and the onset and duration of protection conferred by 
an E2 candidate that uses the novel KNB oil-in-water adjuvant, in 
combination with baculovirus and plant expressed E2, to assess if this 
adjuvant provides sufficient enhancement to protect with a single dose 
(Madera et al., 2018). The incorporation of food-grade saponin into this 
novel oil-in-water-based adjuvant has also been investigated (Burakova 
et al., 2018). A recent study has investigated the use of Gram-positive 
enhancer matrix (GEM) particles for surface display of glycosylated 
E2, expressed in the yeast Pichia pastoris (D. Li et al., 2020a, 2020b, 
2020c). Higher anti-E2 and neutralizing Ab responses were obtained in 
mice immunised with the GEM loaded particles, compared to the E2 
protein alone. Attachment of E2 to gold nanoparticles has also produced 
interesting preliminary results in mice (Li et al., 2020a, 2020b, 2020c) 
and it will be interesting to see if these systems enhance protection in 
pigs. 
Promising enhancement of immunity to E2 subunit vaccine has been 
achieved in the past by inclusion of immunomodulatory proteins, such 
as IFN-α, together with E2 (Toledo et al., 2010). This concept has been 
extended recently to investigate the impact of the inclusion of IFN-γ as 
an immunoadjuvant (H. Zhang et al., 2018a, 2018b). It will be inter-
esting to see if this approach can provide robust protection against 
vertical transmission in pregnant sows. A very recent study has inves-
tigated a system to provide both economic production and enhanced 
immunogenicity by using a transgenic N. benthamiana plant-based 
expression of E2 fused to porcine Fc (Park et al., 2020). 
One of the furthest developed improved E2 subunit vaccines is the 
Porvac vaccine, which is being used in a CSF eradication programme in 
Cuba. This vaccine exploits the porcine CD154 protein, which is the 
ligand of the CD40 molecule, as a novel molecular adjuvant. CD154 is 
expressed transiently on CD4+ T helper cells and engagement with 
CD40 on antigen presenting cells results in their increased activation 
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and maturation. A system for the production of this chimeric E2-CD154 
protein by secretion from a stable HEK293 cell line adapted to suspen-
sion culture was generated (Suárez et al., 2017). Both, humoral and 
cellular immune responses in mice were enhanced compared to immu-
nisation of E2 without CD154 in the same adjuvant formulation (Sordo 
et al., 2018). Immunisation with the E2-CD154 fusion protein protected 
pigs from challenge infection as early as 7 days after a single dose 
vaccination. No clinical signs were observed, and no virus was detected 
by virus isolation and by PCR, neither in the blood nor in the tonsils and 
spleens of vaccinated animals (Suárez et al., 2017). Immunisation of 
pregnant sows with two doses of this vaccine also protected against 
vertical transmission after intramuscular challenge with a high dose of a 
highly virulent CSFV (Muñoz-González et al., 2017). Together with good 
surveillance and biosecurity, this vaccine candidate is promising for CSF 
control and eradication in endemic situations. 
10. Final remarks and conclusions 
Despite the extensive efforts in CSFV research, diagnostics and 
eradication, the virus continues to persist and re-emerge, posing a threat 
for food supply in affected regions. There are still numerous gaps in 
understanding the disease immunopathogenesis, the complex virus-host 
interactions and the viral determinants of virulence. In addition, the 
reasons behind the narrow host range of CSFV and the genetic de-
terminants of host susceptibility to CSFV infection also need further 
attention. Understanding of these knowledge gaps will support the 
development of efficient approaches to diagnose and control subclinical 
and persistent infections in domestic pigs and wild boar. Studies aimed 
at understanding CSFV evolution and vaccine escape variants in the field 
are of utmost importance to support eradication efforts. Finally, despite 
significant advances in the development of new DIVA prototype vac-
cines, appropriate DIVA serological tests remain a challenge to be 
resolved in the near future to guarantee disease control supported by 
emergency vaccination. 
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Gómez-Villamandos, J.C., Ruiz-Villamor, E., Bautista, M.J., Quezada, M., Sánchez, C.P., 
Salguero, F.J., Sierra, M.A., 2000. Pathogenesis of classical swine fever: renal 
haemorrhages and erythrodiapedesis. J. Comp. Pathol. 123, 47–54. https://doi.org/ 
10.1053/jcpa.2000.0385. 
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